Advanced Search

 

Study ID Status Title Patient Level Data
29060/790 Completed A Double-blind, Placebo-controlled, Flexible-dose Study of Paroxetine CR in the Treatment of Patients with Social Anxiety Disorder Study Listed on ClinicalStudyDataRequest.com
29060/791 Completed A Randomized, Double-Blind, Placebo-Controlled, Flexible Dosage Trial to Evaluate the Efficacy and Tolerability of Paroxetine CR in Patients with Generalized Anxiety Disorder (GAD) Study Listed on ClinicalStudyDataRequest.com
29060/799 Completed BRL29060A in Posttraumatic Stress Disorder
29060/810 Completed A double-blind, placebo-controlled, 3-arm, fixed-dose study of 12.5 mg/day and 25mg/day Paroxetine CR in the treatment of Major Depression. Study Listed on ClinicalStudyDataRequest.com
29060/863 Completed A Post-Marketing Clinical Study of PAXIL Tablet in Patients with Depression or Depressive Episodes
29060/874 Completed A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Fixed Dose Study Evaluating the Efficacy and Safety of Paroxetine CR in Elderly Outpatients Diagnosed with Major Depressive Disorder Study Listed on ClinicalStudyDataRequest.com
29060/877 Completed An open labeled, single sequence study to investigate the safety and pharmacokinetics of oral pimozide when co-administered with repeat dosing oral paroxetine 60 mg od in healthy volunteers. Study Listed on ClinicalStudyDataRequest.com
300 Completed A Multicenter Trial of Bupropion for Cocaine Dependence in Methadone-Maintained Patients – Extensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication; see citation below.
30310/001 Completed An open, multicentred, non-comparative study to assess the efficacy, safety and tolerability of a single 400mg po dose of Oxibendazole in the treatment of intestinal helminth infections in adults
30310/002 Completed A multicentre, randomised, double-blind, parallel group study to assess the efficacy, safety and tolerability of a single 400mg po dose of Oxibendazole versus a single 500mg po dose of Mebendazole in the treatment of intestinal helminths in adults
30310/003 Completed A single centre randomised open non comparative study to assess the does response efficacy safety & tolerability of a single 200mg, 400mg or 600mg po dose of Oxibendazole in the treatment of intestinal helminth infections in adults
30310/004 Completed An open , non comparative study to assess the safety and efficacy , safety and tolerability of a single 400mg PO dose of oxibendazole in intestinal helminth infections in adults
30310/007 Completed A multicentre randomised parallel group study to assess the efficacy safety and tolerability of a single 400mg po dose of Oxibendazole suspension versus a single 500mg dose of Mebendazole tablet in the treatment of intestinal helminth infections in childre
30310/013 Completed A study to investigate the bioavailability of oxibendazole in healthy volunteers
3065A1-100 Completed Clinical trial to assess safety, tolerability and pharmacokinetics of orally administered Retigabine in healthy male volunteers
3065-A1-101 Completed Investigation into the tolerability, safety and steady state kinetics after repeated oral administration for 29 days of D-23129 in healthy volunteers
3065A1-102 Completed Ascending multiple dose tolerance study of retigabine in healthy male subjects
3065A1-103 Completed Relative Bioavailability of Retigabine (D-23129) from various modified release formulations (TESTS) versus immediate release capsule (REFERENCE) in healthy male volunteers
3065A1-104 Completed The effects of a high-fat meal on the pharmacokinetics of two sustained release formulations of retigabine (GKE-841;D-23129) in healthy male subjects
3065A1-105 Completed Effect of age and sex on the pharmacokinetics of retigabine
3065A1-106 Completed Food Interaction Study of Retigabine in Healthy Volunteers of Both Sexes
3065A1-107 Completed A 30-day safety and tolerability study of various titration regimens of retigabine in healthy male subjects
3065A1-108 Completed A study of the metabolic pathways and mass balance of orally administered [14C]-labeled Retigabine in healthy male subjects
3065A1-109 Completed An open-label, drug interaction study of retigabine and lamotrigine in healthy male subjects
3065A1-110 Completed A Comparative Bioavailability study of three oral dose formulations of retigabine in healthy adult subjects

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.